<DOC>
	<DOCNO>NCT00771368</DOCNO>
	<brief_summary>The purpose study determine gaseous nitric oxide effective treatement bacteria MRSA positive ulcer</brief_summary>
	<brief_title>Reduction Bacteria MRSA Positive Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Must give write informed consent Must 19 year age Must ulcer lesion presence MRSA positively identify clinically infect . Must Ulcer / Lesion size extend beyond inner border wound cover Is female pregnant , nursing , child bear potential use adequate form contraception ( abstinence ) Is &lt; 19 year age Has clinically infect ulcer Has Ulcer / Lesion currently treat treated topical antimicrobial agent 3 day prior enrolment . Has use systemic antibiotic 7 day prior enrolment study . Has Ulcer / Lesion identify malignant origin ( e.g. , Marjolin 's ulcer ) Has Ulcer / Lesion size beyond inner border wound cover Is septic sign invasive infection Has use investigational product within 30 day precede study participation . Suffers condition , , opinion Investigator , would compromise safety . Suffers condition , opinion Investigator , would compromise quality data . Has know allergy product part protocol Suffers condition , opinion Investigator , would seriously interfere negatively normal parameter immune response infection . Is use prohibit concomitant medication treatment</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>